KPTI
#4325
Karyopharm Therapeutics Inc. - Common Stock
1.8 8 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.09%
Monthly Change
-73.30%
6 month change
-79.48%
Year Change
-80.50%
Previous Close
1.9 4
Open
1.8 7
Low
1.8 6
High
1.8 9
Volume
92
Financials
- Market Capitalization 42.64 M
- Employee 228
- Founded 2008
- CEO N/A
- Website www.karyopharm.com
- Headquarter Delaware, United States
- FIGI BBG001J272L7
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.41
Price to sales ratio
0
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4319 |  MREO Mereo BioPharma Group plc - American Depositary Shares | 0.25 USD | -7.41% | -13.79% | -19.35% | -85.71% | 39.92 M USD | ||
| 4323 |  ALGS Aligos Therapeutics, Inc. - Common stock | 6.85 USD | -3.11% | +2.39% | +63.10% | -30.03% | 42.72 M USD | ||
| 4341 |  ACTU Actuate Therapeutics, Inc. - Common stock | 1.70 USD | +0.59% | +30.77% | +55.96% | -58.33% | 40.82 M USD | ||
| 4356 |  CRVO CervoMed Inc. - Common Stock | 2.61 USD | -1.14% | -0.38% | +4.40% | -72.26% | 39.46 M USD |
Frequently asked questions about Karyopharm Therapeutics Inc.
What is the Karyopharm Therapeutics Inc. stock price today?
The current price of Karyopharm Therapeutics Inc. (KPTI) is 1.88. Over the past 24 hours, the stock has changed by -3.09%. Follow the KPTI chart for real-time price dynamics.
What is the stock ticker of Karyopharm Therapeutics Inc.?
Karyopharm Therapeutics Inc. trades under the ticker KPTI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Karyopharm Therapeutics Inc. stock going up?
KPTI has changed by -1.57% over the last week, -73.30% over the last month, and -80.50% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Karyopharm Therapeutics Inc.?
Karyopharm Therapeutics Inc. currently has a market capitalization of 42.64 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Karyopharm Therapeutics Inc. earnings last quarter?
Last quarter, Karyopharm Therapeutics Inc. reported earnings of -2.32 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Karyopharm Therapeutics Inc. revenue for the last quarter?
Karyopharm Therapeutics Inc. reported quarterly revenue of 33.43 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Karyopharm Therapeutics Inc. net income for the last quarter?
Karyopharm Therapeutics Inc. reported net income of -67.02 M for the last quarter. The previous quarter showed -22.39 M, which means net income changed by -199.32%.
How many employees does Karyopharm Therapeutics Inc. have?
As of the latest available data, Karyopharm Therapeutics Inc. has 228 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Karyopharm Therapeutics Inc. stock?
You can buy Karyopharm Therapeutics Inc. (KPTI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Karyopharm Therapeutics Inc. stock?
Investing in Karyopharm Therapeutics Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KPTI chart and related analysis on metatrader.com as part of your research.